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ABSTRACT The interaction of caldesmon domains with tropomyosin has been studied using x-ray crystallography and an
optical biosensor. Only whole caldesmon and the carboxyl-terminal domain of caldesmon (CaD-4, chicken gizzard residues
597-756) bound to tropomyosin with greater than millimolar affinity at 100 and 150 mM salt. Under these conditions the
affinities of whole caldesmon and CaD-4 were both in the micromolar range. Data from the x-ray studies showed that whole
caldesmon bound to tropomyosin in several places, with the region of tightest interaction being at tropomyosin residues
70-100 and/or 230-260. Studies with CaD-4 revealed that this region corresponded to the strong binding site seen with
whole caldesmon. Weaker association of other regions of caldesmon to tropomyosin residues 180-210 and 5-50 was also
observed. The results suggest that the carboxyl-terminus of caldesmon binds tightly to tropomyosin and that other regions
of caldesmon may interact with tropomyosin tightly only when they are held close to tropomyosin by the carboxyl-terminal
domain. Four models are presented to show the possible interactions of caldesmon with tropomyosin.
INTRODUCTION
Regulation of smooth muscle contraction is primarily me-
diated by phosphorylation of myosin light chains by myosin
light chain kinase complexed with Ca+2-calmodulin (Allen
and Walsh, 1994). A number of experiments, however,
indicate that the phosphorylation of myosin cannot account
for all of the observed behaviors of smooth muscle (Allen
and Walsh, 1994). The observation of in vitro calcium-
regulated inhibition of actomyosin ATPase by smooth mus-
cle thin filaments led to the suggestion that smooth muscle
may contain a thin filament regulatory system similar to the
troponin system found in all striated muscle (Hemric et al.,
1993; Marston and Smith, 1985).
Caldesmon, identified as a possible thin filament regula-
tory switch in smooth muscle (Sobue et al., 1981), is an
89-kDa elongated protein that binds tightly to myosin, actin,
tropomyosin, and several calcium-binding proteins, includ-
ing calmodulin (Marston and Redwood, 1991). In reconsti-
tuted systems caldesmon inhibits the actin-activated
ATPase activity of myosin by several different mechanisms:
1) inhibition of weak cross-bridge binding between actin
and myosin; 2) cross-linking of actin and myosin, which can
impede filament movement; and 3) tropomyosin-dependent
inhibition (Kraft et al., 1995; Marston et al., 1994a). All of
these inhibitions are diminished by the binding of Ca+2/
calmodulin to caldesmon, which reduces the affinity of
caldesmon for actin, tropomyosin, and myosin (Watson et
al., 1990a).
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Caldesmon probably plays a significant role in the thin
filament calcium regulation of smooth muscles, because
antibodies to caldesmon abolish calcium sensitivity of mus-
cle actin-activated myosin ATPase (Marston et al., 1988).
Further evidence of caldesmon's importance comes from
studies where thin filaments were reconstituted with phys-
iological ratios of caldesmon, tropomyosin, and actin (2:1:
14) (Dabrowska et al., 1985; Smith et al., 1987). These
filaments are calcium regulated in the presence of calmod-
ulin. Other studies using caldesmon fragments suggest that
caldesmon regulates contraction in some smooth muscle
cells by providing a basal resting inhibition of vascular tone
(Katsuyama et al., 1992).
Many studies using segments of caldesmon have been
conducted in an attempt to define the functional domains of
caldesmon. Several binding sites have been identified in
vitro for actin, myosin, calmodulin, and tropomyosin. It has
been suggested that caldesmon is composed of four domains
joined by mainly unstructured polypeptide regions (Marston
and Redwood, 1991). Domain 1 is at the amino terminus
and is believed to bind to myosin. Domain 2 is known as the
central repeating helical region and is absent in nonmuscle
isoforms. Domain 3 contains a region with homology to
troponin T. Domain 4, the C-terminal part of caldesmon, is
known to include most of the regulatory properties of the
entire molecule and includes the binding sites for actin,
calmodulin, myosin, and tropomyosin. The C-terminal do-
main has been further subdivided into two pieces, domain
4a (chicken gizzard residues 600-657) and domain 4b
(residues 658-756) (Redwood and Marston, 1993).
Most studies done with caldesmon fragments have re-
ported that each of the four domains retains most of its
functional properties when separated from the rest of the
molecule. Experiments have determined that most of the
regulatory functions of caldesmon are contained in domain
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4b, the carboxyl terminal 99 amino acids (Bartegi et al.,
1990; Redwood and Marston, 1993). It has also been shown
that this fragment of caldesmon can regulate smooth muscle
filaments in a way analogous to that of TnI in striated
muscles (Fraser and Marston, 1995; Marston et al., 1994a).
However, this 99-residue fragment does not bind apprecia-
bly to tropomyosin, suggesting that other regions of caldes-
mon are responsible for structural interactions with tropo-
myosin (Huber et al., 1995; Redwood and Marston, 1993).
Although caldesmon has been extensively studied, the
only structural information available about caldesmon and
its various complexes comes from several electron micros-
copy (EM) studies. Rotary shadowing EM studies of single
caldesmon molecules revealed an elongated shape approx-
imately 76-80 nm long (Mabuchi and Wang, 1991). Some
negatively stained thin filaments have also been studied,
with EM apparently showing caldesmon wound around the
actin helix (Moody et al., 1990). A more recent study also
examined the structure of negatively stained native thin
filaments from smooth muscle using EM (Vibert et al.,
1993). Although they could not directly visualize caldes-
mon, they did not observe any projections away from the
thin filament, suggesting that caldesmon is in close associ-
ation with the thin filament along its entire length, leading
to models in which caldesmon and tropomyosin are bound
side by side (Marston and Redwood, 1991; Moody et al.,
1990; Watson et al., 1990b). They also noted that the
position of tropomyosin was shifted away from the myosin-
binding sites on actin without calcium. The results of an-
other set of EM studies also suggest that both ends of
caldesmon interact with native thin filaments (Mabuchi et
al., 1993). Last year, additional structural studies were pub-
lished showing that only domain 4 of caldesmon (the car-
boxyl-terminal fragment) bound tightly to reassembled tro-
pomyosin:actin filaments and that domains 1 and 2
projected away from the thin filament under some condi-
tions (Katayama and Ikebe, 1995). Other studies have found
that reassembled thin filaments are indistinguishable from
native thin filaments (Hodgkinson et al., unpublished data).
A series of fluorescence and affinity chromatography
studies with fragments of both caldesmon and tropomyosin
have also been used to identify which pieces interact (Huber
et al., 1995; Redwood and Marston, 1993; Tsuruda et al.,
1995; Watson et al., 1990a,b). Several of these studies have
also suggested that caldesmon:tropomyosin-binding sites
are discrete but extended (Huber et al., 1995; Watson et al.,
1990b). The results of these studies suggest that almost
every region of caldesmon can bind to some part of tropo-
myosin under certain conditions and that the carboxyl-
terminal domain of caldesmon contains a strong tropomy-
osin-binding site.
In this paper the first detailed three-dimensional struc-
tural information about the interactions of caldesmon and
tropomyosin determined using x-ray crystallography is re-
ported. The binding of both full-length and several frag-
ments of caldesmon to tropomyosin has also been examined
quantify the binding specificity and strength of each caldes-
mon domain.
MATERIALS AND METHODS
Protein purification
Skeletal aa tropomyosin was purified from rabbit skeletal muscle by
previously published methods (Whitby et al., 1992; White et al., 1987).
Chicken skeletal aa and gizzard a/3 tropomyosins were purified using the
same basic procedure. Unacetylated chicken skeletal tropomyosin was
expressed in bacteria and purified as previously reported (Hitchcock-
DeGregori and Heald, 1987). Bovine serum albumin (BSA) was purchased
from Sigma Chemical Co.
All caldesmon fragments are based on the sequence of chicken gizzard
caldesmon (Bryan et al., 1989). CaD-1 (residues 1-128) and CaD-2 (230-
419) were expressed as described by Redwood and Marston (1993). Full-
length caldesmon was purified from chicken gizzard according to the
method of Lynch and Bretscher (1986). Caldesmon fragments CaD-4
(597-756) and CaD-3 (413-579), were generated by recombinant methods
and expressed in E. coli using a T7-promoter-based expression vector
pAED4. CaD-4 was purified using a slight variation of a previously
published procedure (Wang et al., 1991). Briefly, the bacterial cell extracts
were first heated at 100°C for 15 min, followed by centrifugation; the
supernatant was loaded onto a calmodulin-affinity column in the presence
of Ca2+. After washing with Ca2+ buffer, the bound fractions were eluted
from the column with an EDTA-containing buffer; the CaD fragment thus
obtained was further purified on a DE-52 ion exchange column. CaD-3 was
purified by a similar procedure (J. Kordowska, unpublished observation).
Briefly, the bacterial extract was heated and spun as above, and the
supernatant was first applied to a DE-52 column at pH 7. CaD-3 did not
bind and was collected in the flow-through fractions. After the pH was
adjusted to 5, the pooled fractions were loaded onto a CM-52 cation
exchange column equilibrated at pH 5. CaD-3 was then eluted from the
column with a salt gradient. MG56C (658-713) was purified from E. coli
as described (Zhuang et al., 1995). Recombinant chicken brain calmodulin
(CaM) was purified from E. coli by phenyl-Sepharose column chromatog-
raphy (Dedman and Kaetzel, 1983). Protein concentrations were deter-
mined spectrophotometrically using the following molar extinction coef-
ficients (cm-' M-'): tropomyosin, 15,800 at 277 nm; whole caldesmon,
28,990 at 280 nm; CaD-4, 8600 at 280 nm; CaD-3, 5600 at 280 nm;
MG56C, 11,200 at 280 nm; CaM, 3300 at 277 nm. Protein concentrations
for CaD-1 and CaD-2 were estimated using the Lowry method (Lowry et
al., 1951).
Crystallization
Tropomyosin crystals (Bailey, 1948) were grown in capillary tubes by
liquid-liquid diffusion as previously described (Chacko and Phillips, 1992;
Phillips, 1985). The protein concentration was 10 and 12 mg/ml, and the
pH was between 5.6 and 5.9 in 100 mM NaCl and 50 mM ammonium
sulfate. These crystals are composed of tropomyosin filaments connected
head to tail, running parallel to the body diagonal of the unit cell (space
group P21212 with a = 120 A, b = 240 A, c = 300 A). The crystals are
greater than 95% solvent, which limits diffraction resolution to around 15
A. However, the open mesh formed by the tropomyosin filaments provides
ample space to soak other proteins into the crystal lattice, such as troponin
and caldesmon, which can then bind to the tropomyosin filaments. Because
Bailey crystals are extremely fragile as grown, the crystals were lightly
cross-linked with 0.1% glutaraldehyde to stabilize them. In earlier work
with troponin, this treatment was shown not to affect the interactions of
troponin and tropomyosin (White et al., 1987). Earlier studies examining
troponin binding to Bailey tropomyosin crystals were done with the tro-
pomyosin crystals as grown, at pH -5.8 and an ionic strength of about 150
mM (White et al., 1987). However, caldesmon binding to tropomyosin is
using an evanescent wave optical biosensor in an attempt to
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reported to be ionic strength dependent and varies with pH (Marston and
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Redwood, 1991). For these studies with caldesmon, the pH of the crystals
was gradually changed to pH 7 and the ionic strength was lowered to
30-60 mM imidazole before whole caldesmon or fragments were then
layered onto the crystal and allowed to diffuse into the crystal for several
hours before x-ray data were collected.
Data collection and processing
X-ray diffraction data were collected on a Siemens area detector, rotating
anode system equipped with Franks double focusing mirrors to obtain a
finely focused beam. The detector-to-crystal distance was 295 mm, and a
helium path was used to minimize air scattering of X-rays. The beam stop
was made as small as possible and was suspended on a thin strip of mylar
a few millimeters from the detector surface to allow the collection of
low-resolution reflections. The Bailey crystals are fragile and deteriorate
slowly at room temperature, so the data were collected at about 4°C; a
stream of cold air was used to cool the crystal. For a typical crystal several
hundred 200-400-s frames were collected as 0.2-0.4° oscillations. The
data were processed using the XDS software package (Kabsch, 1988). The
co-crystals diffracted x-rays to 16-20-A resolution (Table 1). Whole
caldesmon and native tropomyosin data sets were collected from single
crystals. Data from the two diffraction experiments with CaD-4 were
scaled and merged using the program XSCALE (Kabsch, 1988).
Difference maps and phase refinement
Initial phases for the co-crystal electron density maps were based on pure
tropomyosin phases and were improved by solvent flattening and figure-
of-merit weighting (White et al., 1987). The Bailey crystals are greater than
95% solvent, so the initial maps were multiplied by a mask with values of
0 in most of the solvent region and values of 1 at and around the
tropomyosin filaments with a radius of -30 A. The resulting map was then
used to generate a new set of phases. This flattening was repeated several
times until the intensity-weighted root-mean-squared difference of the
phases between two cycles was less than 100. Fourier difference maps were
calculated using coefficients generated by subtracting native tropomyosin
data from the caldesmon:tropomyosin data. The resulting electron density
maps were visualized using the program CHAIN (Sack, 1988). Figs. 2 and
3 were generated using the program MOLSCRIPT (Kraulis, 1991).
Biosensor binding experiments
All kinetic experiments were done using an lAsys optical biosensor fol-
lowing the manufacturer's recommended procedures (Fisons Applied
Technology, Cambridge, England). An amino coupling kit (containing
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, N-hydroxy-succinimide,
and 1 M ethanolamine, pH 8.5) and lAsys carboxymethyl dextran (CMD)
cuvettes were purchased from Fisons Applied Sensor Technology. Tropo-
myosin was immobilized to the CMD cuvettes, via its amino groups, as
previously described for other proteins (Davies et al., 1994). Several
cuvettes were treated with an average of 13 ng/mm2 of tropomyosin
immobilized to each 18-mm2 cuvette surface. The binding (or lack of
binding) of whole caldesmon and caldesmon fragments to immobilized
tropomyosin was assessed. For each binding assay the cuvette was equil-
ibrated with 200 ,ul of buffer (50-150 mM NaCl, 10 mM phosphate, 1 mM
EDTA, 1 mM DTT, 2 mg/ml BSA, pH 7.4) for several minutes. Protein
samples (2-40 ,ul) were then added and allowed to bind for several
minutes. After the association was measured, the cuvette was emptied and
filled with a fresh 200 ,ul of buffer, and the dissociation was followed for
several minutes. Each sample was analyzed at several concentrations, and
every concentration was tested at least twice.
Data were analyzed with the FASTfit software package provided with
the lAsys instrument. The details of data analysis using this software have
previously been described and involve a nonlinear regression fit of two
integrated rate equations to the data (Davies et al., 1994; Edwards et al.,
1995; George et al., 1995). Raw data were also exported and then pro-
cessed using the Igor Pro software package and integrated rate equations.
On the biosensor surface the reaction between the immobilized protein
(I) and the free ligate (L) can be described as a simple reversible reaction
between two homogeneous species such that
kass
L + I LI.
kdiss
The observed rate constant (k,hbs) is defined as
kobs = (kass EL] + kdiss).
(1)
(2)
In the lAsys the amount of LI (protein complex) is measured directly as the
response (R) of the machine in units of arc seconds. The [IL] at equilibrium
can be called the extent (E) of reaction. Thus the association of a ligate to
an immobilized protein can be described by the following pseudo-first-
order rate equation:
Rt = Ro + E(1 - e-kobt) (3)
where Rt is the instrument response at time t and Ro is the response
immediately before the ligate is added to the cuvette. The FASTfit software
uses an iterative nonlinear least-squares curve-fitting procedure to derive
values of kobs and E from the data. As can be seen from Eq. 2, a plot of kobs
against [L] should give a straight line with a y-axis intercept of kdiss and a
slope of kass. A related equation can also be used to fit data assuming two
different rate constants:
Rt = Ro + E1(1 -e obsit) + E2(1 - e-kbs(2)t) (4)
RESULTS
The interactions of several caldesmon domains with tropo-
myosin have been examined. Structures of co-crystals of
TABLE 1 Crystal statistics for tropomyosin crystals and co-crystals
Unit cell (A) Rsym (%) Rsym (%)Completeness Y m
Soaked protein* (%) to 16 A a b c (all data) (I > 3 ar)
wCaD 99.0 123.5 x 244.5 x 291.4 22.9 10.1
CaD-4 (data set 1) 80.8 112.7 X 242.8 X 300.8 19.9 10.0
CaD-4 (data set 2) 43.2 124.4 x 239.9 x 296.6 25.1 11.5
CaD-4 (merged data) 93.0 27.0 11.0
CaD-3 98.6 117.4 X 238.1 X 294.7 17.9 9.5
none 99.3 116.0 x 240.0 x 299.1 14.2 8.0
*Proteins soaked into Bailey tropomyosin crystals: wCaD, whole chicken caldesmon; CaD-4, caldesmon residues 597-756; CaD-3, residues 413-579; none,
no additional protein.
#RsYM = lhEjliki - Ihl/y-hyi i, where Ih is the intensity of reflection h, Yh is the sum over all reflections, and Ii is the sum over all i measurements of
reflection h.
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tropomyosin with whole caldesmon and caldesmon domain
4 (CaD-4) were determined by x-ray crystallography. The
electron density maps revealed which regions of tropomy-
osin interacted with caldesmon and showed that several
domains of caldesmon bound to tropomyosin at low ionic
strength. A brief account of the crystallography results was
previously reported (Hnath and Phillips, 1995). The binding
of whole caldesmon and fragments to immobilized tropo-
myosin was measured using an optical biosensor. Only
whole caldesmon and CaD-4 bound to tropomyosin with
micromolar affinity under near-physiological salt condi-
tions, whereas none of the other fragments bound specifi-
cally at 100 mM or higher salt.
Tropomyosin-caldesmon co-crystals
Whole caldesmon or fragments were layered onto tropomy-
osin crystals and allowed to soak into the crystals for several
hours. Data were then collected of these "co-crystals" (Ta-
ble 1). Although the Rsym for all data is high, this is due
primarily to the many weakly diffracting reflections that are
characteristic of the highly anisotropic diffraction patterns
of these tropomyosin crystals. Earlier studies with troponin
indicated visible changes in the diffraction pattern of Bailey
crystals with troponin bound to them, the most obvious
changes being in the OKL reflections. Comparison of dif-
fraction patterns from tropomyosin:caldesmon co-crystals
and tropomyosin:troponin co-crystals to native tropomyosin
crystals showed similar changes, suggesting that caldesmon
had bound inside the crystal (Fig. 1).
Structure of whole caldesmon:
tropomyosin crystals
Difference Fourier maps were used to locate the position of
caldesmon in the tropomyosin crystals. Because caldesmon is
almost twice the length of tropomyosin, a clean map of caldes-
mon on the tropomyosin lattice was not anticipated. It was
expected that only caldesmon's attachment site(s) on tropomy-
osin would be visible. The map showed that caldesmon bound
tropomyosin in several places over most of the tropomyosin
molecules (Fig. 2). One region of caldesmon bound close to
the region where the tropomyosin filaments cross over each
other, near tropomyosin residues 70-100 and residues 230-
260 of the nearby molecule; another part of caldesmon bound
near residues 160-210; and a final part of caldesmon inter-
acted with tropomyosin residues 5-50. Contouring at higher
levels revealed that the strongest binding site was near the
tropomyosin residues 70-100 and residues 230-260 of a sym-
metry-related tropomyosin molecule and a slightly weaker site
near tropomyosin 190-210. Caldesmon did not appear to di-
rectly bind to the head-to-tail overlap region.
Structure of CaD-4:tropomyosin co-crystals
To help define which region of caldesmon was binding to
the tropomyosin crystal, data were also collected where the
C-terminal portion of caldesmon (CaD-4) had been soaked
into a crystal. Examination of the calculated difference map
(Fig. 3 A) revealed some density near the cross-over region
of the tropomyosin molecules. The density was in a place
similar to that of the strongest binding region seen with
whole caldesmon. Another difference map was calculated,
subtracting the CaD-4 data set from the whole caldesmon
data (Fig. 3 B). This map shows a density similar to that of
the whole CaD-tropomyosin map, except for the density
near tropomyosin residues 70-100 and residues 230-260.
This confirmed that the CaD-4 fragment had bound to the
tropomyosin crystal and that CaD-4 contained the strongest
binding sites seen in the whole caldesmon map. However, it
was still not known which other region(s) of caldesmon was
responsible for the electron density seen in the whole
caldesmon maps near tropomyosin 190 and near the amino
terminus.
Other caldesmon domains
Earlier studies suggested that caldesmon domain 3
(CaD-3) might bind to tropomyosin, based on its 43%
identity to TnT residues 89-147 and the fact that this
k
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FIGURE 1 Observed diffraction data from one crystallographic plane of Bailey tropomyosin crystals. From left to right are data from crystals of pure
tropomyosin, tropomyosin:troponin, tropomyosin:caldesmon, and tropomyosin:CaD-4. Unique reflections to 16 A are shown.
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FIGURE 2 Stereo difference maps of whole caldesmon:tropomyosin crystal electron density minus pure tropomyosin showing the extra density (in black)
corresponding to caldesmon in the crystal. Two overlapping tropomyosin molecules are shown with electron density within a 30-A radius. Nearby
symmetry-related tropomyosin molecules are also shown. (A) Difference map contoured at 2 sigma. (B) Map contoured at 3 sigma.
region of TnT binds to tropomyosin (Bryan et al., 1989;
White et al., 1987). Therefore, several attempts were
made to collect data sets with CaD-3 soaked into Bailey
crystals. Significant changes in the diffraction patterns
were not observed in any of these data sets. Difference
maps subtracting pure tropomyosin from the tropomyo-
sin:CaD-3 data did not reveal any significant extra den-
sity (data not shown). Furthermore, a difference map of
whole caldesmon minus CaD-3 looked almost identical to
the whole caldesmon minus pure tropomyosin map, con-
firming that CaD-3 had not bound to the crystals. At this
point it was still not clear which other region of caldes-
mon was binding to tropomyosin in the crystals or if there
were differences in the binding of caldesmon to skeletal
and smooth muscle tropomyosin. Therefore it was de-
cided to examine the binding of caldesmon domains to
tropomyosin by another method.
Biosensor binding studies
The new optical biosensors based on evanescent-wave de-
tection provide a relatively facile way to assess the affinity
1924 Biophysical Journal
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FIGURE 3 Stereo difference maps showing the binding of CaD-4 to tropomyosin in the Bailey crystal. (A) Difference map of a CaD-4:tropomyosin minus
pure tropomyosin (contoured at 2.5 sigma). (B) Difference map of whole caldesmon minus CaD-4, showing that CaD-4 does indeed bind to the node region
(contoured at 2.25 sigma). The remaining density seen in the second map suggests that caldesmon does have other regions, besides CaD-4, that bind to
tropomyosin near tropomyosin residues 180-210 and 5-50.
of caldesmon domains for tropomyosin under a variety of
conditions (Yeung et al., 1995). The use of an optical
biosensor requires that one of the biomolecules be immo-
bilized, and because the goal was to examine the binding of
several fragments of caldesmon to tropomyosin, tropomyo-
sin was immobilized. It was thought this choice might also
simplify the observed kinetic data, because tropomyosin
binds to itself in a head-to-tail manner.
Initial measurements of caldesmon domains binding to
skeletal and smooth muscle tropomyosin were done in 150
mM NaCl, 10 mM phosphate (pH 7.4). However, the bind-
ing of most of the fragments was weak under these condi-
tions. Binding measurements at 100 mM and 50 mM NaCl
were attempted to see if binding occurred under these con-
ditions. However, nonspecific binding (as determined by
binding of caldesmon domains to immobilized myoglobin
and BSA) was observed for most of the caldesmon frag-
ments as well as for whole caldesmon. To circumvent this
problem, 2 mg/ml BSA was added to all of the buffers. This
experimental protocol helped in most cases, although non-
1925Hnath et al.
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specific binding was still observed at 50 mM NaCl for some
of the caldesmon domains and at caldesmon concentrations
above 2 ,uM.
The raw data from the IAsys were processed using the
FASTfit software package provided with the instrument and
with the Igor Pro software package. The results obtained
from both methods were indistinguishable. Two types of
analysis were undertaken, providing kinetic and equilibrium
binding affinities. For the kinetic analysis, values of ka and
kdiSs were derived from the data which were then used to
calculate the overall affinity (kdiss/kass = KD (M)). The
equilibrium binding affinities were calculated by plotting
the extent of binding against concentration. The result is a
standard equilibrium binding curve, where the KD is the
concentration required for half-maxium binding.
Whole caldesmon and CaD-4
binding to tropomyosin
The binding of several different caldesmon domains to
tropomyosin was examined, but only whole caldesmon and
CaD-4 bound with strong, specific affinity (Table 2). The
whole caldesmon and CaD-4 binding curves indicated that
equilibrium was nearly achieved in a few minutes and that
the equilibrium KD could be directly estimated in addition to
calculating it as the ratio of the rate constants (Fig. 4). Some
typical examples of the analysis for whole caldesmon and
CaD-4 binding to tropomyosin are shown in Figs. 5 and 6.
As is often observed in biosensor data, the association rate
curves were biphasic, with the second phase being -10-fold
slower than the first phase. The slower phases of data from
biosensor experiments with unoriented immobilized pro-
teins are, for the most part, disregarded, as they probably
TABLE 2 Caldesmon fragments binding to tropomyosin
Ligate* Immobilized* NaCl (mM) Affinity, (M)
wCaD
wCaD
CaD-4
CaD-4
CaD-4
wCaD
wCaD
CaD-4
CaD-4
wCaD
wCaD
wCaD
CaD-4
CaD-1, CaD-2,
rsTm
cgTm
rsTm
cgTm
unTm
rsTm
unTm
rsTm
cgTm
rsTm
cgTm
unTm
cgTm
150
150
150
150
150
100
100
100
100
50
50
50
50
0.9 ± 0.6 x 10-6
1.0 ± 0.7 x 10-6
1.9 ± 1.3 x 10-6
1.5 ± 0.5 x 10-6
1.5 ± 0.7 X 10-6
5.6 ± 5.1 x 10-7
4.2 ± 2.2 X 10-7
9.2 ± 4.6 X 1o-7
8.5 ± 2.6 x 10-7
3.1 ± 2.3 x 1O-7
1.3 ± 0.4 x 10-7
1.5 ± 0.4 x 10-7
2.5 ± 3.0 x 10-7
CaD-3, MG56C rsTm, cgTm 100, 150 Not detectable
CaD-3, MG56C rsTm, cgTm 50 Not detectable
CaD-l, CaD-2 rsTm, cgTm 50 Not specific
*Caldesmon fragment: wCaD, whole chicken caldesmon (residues 1-756);
CaD-4, residues 597-756; CaD-1, residues 1-128; CaD-2, residues 230-
419; CaD-3, residues 413-579; MG56C, residues 658-713.
#Immobilized tropomyosin: rsTm, aa-rabbit skeletal; cgTm, al3-chicken
gizzard; unTm, aa-unacetylated chicken skeletal.
*Affinity calculated from equilibrium data.
0 20 40 60 80 100 0 20 40 60 80 100
Time (seconds) Time (seconds)
FIGURE 4 Binding of whole caldesmon (left) and CaD-4 (right) to
immobilized chicken gizzard tropomyosin in 150 mM NaCl, 10 mM
phosphate (pH 7.2), 1 mM DTT, 1 mM EDTA, and 2 mg/ml BSA. The
concentrations shown are (from top to bottom) 1550, 775, and 387 nM for
whole caldesmon and 1875, 937, and 375 nM for CaD-4. Each concentra-
tion was measured at least twice. Clearly the rate of association increases
with concentration. The binding is almost complete after 100 s, at the
concentrations examined, and the curve fitting software could easily ex-
trapolate to equilibrium. Similar concentration dependencies were seen for
all assays of caldesmon and CaD-4 binding to tropomyosin.
represent the behavior of less than fully active protein and
usually comprise less than 30% of the total binding response
(Edwards et al., 1995). Unfortunately, all of the caldesmon
binding curves had two phases, both -50% of the total
curve and with apparently different association and disso-
ciation rates but similar overall affinities (Fig. 7 and Table
3). These data made it difficult to ignore the slower asso-
ciation rate, because it seemed to correspond to a similarly
slower dissociation rate. It was difficult to see a clear pattern
in the association and dissociation rates, but examination of
the equilibrium affinities showed that caldesmon binding to
three types of tropomyosin was similar at each salt concen-
tration and that the affinity became looser with increasing
salt (Table 3). While a highly accurate measure of KD
requires rate and binding measurements that range well
above the concentration that is the KD, nonspecific binding
did not permit rounding out the data set with concentrations
at the high end of the range. Thus the authors acknowledge
that these measurements of KD are only the most accurate
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FIGURE 5 Equilibrium binding analysis of whole caldesmon and CaD-4
interacting with immobilized tropomyosin. Extrapolated binding extents
were plotted against whole caldesmon (left) and CaD-4 (right) concentra-
tion. The line is calculated from the binding constant providing the best fit
for the data. The results of all of the curve fitting analyses are summarized
in Table 2.
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FIGURE 6 Kinetic analysis of the binding of whole caldesmon and
CaD-4 to immobilized tropomyosin. The observed association rates (kobs)
for the binding of caldesmon to tropomyosin were obtained by curve fitting
the association curves shown in Fig. 4. The results were plotted against
caldesmon concentration. The slope of this line is the k.n (association rate),
and the y-intercept is the k0ff (dissociation rate). The results of these plots
and all other kinetic analyses are shown in Table 3.
estimates technically possible for these proteins under these
conditions.
Regulation by calmodulin/calcium
The effect of CaM/Ca2+ on the interaction of tropomyosin
and caldesmon was also examined. While collecting the
CaD-4:tropomyosin kinetic data, instead of simply measur-
ing the dissociation rate, in some experiments we added
fivefold molar excess of calmodulin to the CaD-4 buffer in
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the cuvette after the binding curve appeared to be saturated.
The result was dramatic; CaD-4's affinity for tropomyosin
was quickly reduced, with greater than 90% of the CaD-4
dissociating in less than 10 s (Fig. 8). Adding excess EDTA
to the cuvette reversed the effect, allowing CaD-4 to bind to
tropomyosin, again resulting in another binding curve. Sim-
ilar results were seen for whole caldesmon and the addition
of Ca2+/calmodulin to the cuvette before the addition of
caldesmon or CaD-4 completely inhibited the binding of
whole caldesmon and CaD-4 to tropomyosin.
Different tropomyosins
The binding of caldesmon to different tropomyosins was
examined. Although most of the experiments were done
with rabbit skeletal tropomyosin, caldesmon binding to
chicken gizzard tropomyosin and to unacetylated chicken
skeletal tropomyosin (which cannot polymerize head to tail
like native muscle tropomyosin) was also measured under
some conditions. The affinity of whole caldesmon and
CaD-4 for all three tropomyosins was similar for the con-
ditions examined (Tables 2 and 3).
DISCUSSION
The interactions of whole caldesmon and several domains
of caldesmon with tropomyosin have been examined. Only
whole caldesmon and CaD-4 bound specifically to either
skeletal, smooth, or unacetylated tropomyosin at ionic
strengths above 100 mM. Because specific strong binding
of other fragments by either crystallography or biosensor
technology could not be detected, it appears that if other
domains of caldesmon do bind to tropomyosin, they do so
weakly and/or only when held close to tropomyosin by
domain 4.
Caldesmon and tropomyosin interactions
These results are consistent with work from earlier studies
that suggest that caldesmon can bind along the length of
tropomyosin (Moody et al., 1990; Vibert et al., 1993;
Watson et al., 1990a). EM experiments have previously
shown that caldesmon binds to native thin filaments in a
lengthwise fashion (Mabuchi et al., 1993). Furthermore,
these present results confirm the hypothesis that caldesmon:
tropomyosin-binding sites are discrete but extended (Red-
wood and Marston, 1993; Watson et al., 1990b). The re-
gions of caldesmon that interact with tropomyosin have
been studied by several groups over the years. The results of
earlier studies indicated that caldesmon domains 2 and 4
bound to tropomyosin with the highest affinity (Redwood
and Marston, 1993). A more detailed mapping of the resi-
dues in domains 3 and 4 of human caldesmon that interact
with tropomyosin has recently been reported, and it was
concluded that the strong tropomyosin-binding site is lo-
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FIGURE 7 Curve fitting of whole caldesmon (left) and CaD-4 (right)
binding to tropomyosin. For the top figures the lAsys response is shown on
the left axes and the calculated biphasic binding extents are shown on the
right. Notice that in both cases each extent makes up approximately 50%
of the total binding. Although the binding of CaD-4 seems to be fairly well
described by a double exponential equation, the binding of whole caldes-
mon appears to be multiphasic and is not even fit well, assuming a two-site
attachment. cated in region 4a, but that domain 3 can bind to skeletal,
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TABLE 3 Kinetic data for whole caldesmon and CaD-4 binding to tropomyosin
NaCI k0nI# (M-s-) x i03 kon2 (M-'S-1) X 103 KDI§ (A.M)
Ligate* Immob (mM) k°ff' (s ') koff2 (s ') KD2 KD,' (G,M)
wCaD rsTm 150 320 ± 100 4.9 ± 6.6 0.62 ± 0.58 0.86 ± 0.57
0.20 ± 0.13 0.014 ± 0.008 2.87 ± 5.54
wCaD cgTm 150 300 ± 110 12 ± 4.3 0.97 ± 0.89 1.02 ± 0.74
0.29 ± 0.16 0.0055 ± 0.0050 0.44 ± 0.55
CaD-4 rsTm 150 61 ± 7.8 5.5 ± 6.2 1.15 ± 0.72 1.85 ± 1.30
0.070 ± 0.035 0.0045 ± .0018 0.82 ± 1.25
CaD-4 cgTm 150 120 ± 19 15 ± 5.8 0.86 ± 0.31 1.13 ± 0.56
0.10 ± 0.02 0.015 ± 0.006 1.01 ± 0.80
CaD-4 unTm 150 68 ± 46 6.7 ± 3.9 1.48 ± 2.64 1.40 ± 0.68
0.10 ± 0.11 0.014 ± 0.009 2.08 ± 2.53
wCaD rsTm 100 63 ± 25 NDII 0.71 ± 0.60 0.56 ± 0.51
0.045 ± 0.020
wCaD unTm 100 160 ± 91 ND 0.23 ± 0.63 0.42 ± 0.22
0.036 ± 0.080
CaD-4 rsTm 100 51 ± 8.4 8.7 ± 3.3 0.51 ± 0.22 0.92 ± 0.46
0.026 ± 0.0069 0.0066 ± 0.0027 0.76 ± 0.60
CaD-4 cgTm 100 14 ± 3.3 2.3 ± 1.3 3.60 ± 1.04 0.85 ± 0.26
0.051 ± 0.0029 0.0089 ± 0.0011 3.84 ± 2.58
wCaD rsTm 50 ND ND 0.31 ± 0.23
wCaD cgTm 50 ND ND 0.13 ± 0.04
wCaD unTm 50 380 ± 81 31 ± 14 0.21 ± 0.10 0.15 ± 0.04
0.079 ± 0.020 0.0071 ± 0.0033 0.23 ± 0.21
CaD-4 cgTm 50 ND ND 0.25 ± 0.30
*Ligates and immobilized proteins are as described in Table 2.
#kon are the association rate constants as derived from the slope of plots like Fig. 6. k0ff are the dissociation rate constants as derived from the intercept
of plots like Fig. 6. k0n, and kIn2 represent the values derived from the first phase and the second phase of a biphasic fit of the data.
§Affinity calculated by dividing the koff by the kon.
IAffinity calculated from equilibrium data.
I'Not determinable because of either the absence of a second phase or the inability to fit the data in a congruous manner.
but not smooth, tropomyosin at low ionic strength (Huber et
al., 1995). Some recent EM studies have also shown that the
carboxyl-terminus of caldesmon contains the strong binding
site for tropomyosin (Katayama and Ikebe, 1995), whereas
another laboratory, using a number of caldesmon C-termi-
nal deletion mutants, has proposed a tropomyosin-binding
site in domain 4b (residues 717-727) of caldesmon (Wang
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FIGURE 8 Binding and dissociation of CaD-4 to immobilized skeletal
tropomyosin in the presence and absence of calmodulin. CaD-4 was
allowed to bind to tropomyosin in the same buffer described in Fig. 4
except for the addition of 2 mM calcium. The cuvette was then either
emptied and filled with fresh buffer, or a fivefold molar excess of calmod-
ulin was added.
et al., 1996). The results of a series of cross-linking exper-
iments with caldesmon, tropomyosin, and actin also suggest
that the amino-terminal domain of caldesmon does not
interact with actin or tropomyosin in reconstituted thin
filaments (Graceffa, 1995).
The region of tropomyosin that interacts with caldesmon
has also been investigated over the years. Studies using
affinity chromatography, fluorescently labeled proteins, and
competition assays found that tropomyosin residues 142-
227 have the strongest interaction with caldesmon (Tsuruda
et al., 1995; Watson et al., 1990b). It was also shown that
tropomyosin 11-127 binds caldesmon, but with less affinity
and only in the absence of actin. Furthermore, strong bind-
ing of both caldesmon 1-152 and caldesmon 443-736 to
tropomyosin has been reported (Tsuruda et al., 1995). The
results presented in this paper confirm that the C-terminal
domain of caldesmon does bind tropomyosin, but that a
different region of tropomyosin (70-100 and 230-260)
interacts with caldesmon tightly. It should be noted that
these studies are direct measurements of intact tropomyosin
molecules, whereas the 142-227 assignment is based on the
properties of tropomyosin fragments. Because this current
study did not examine any caldesmon fragments that in-
cluded caldesmon 129-229, it is possible that another
strong tropomyosin-binding site requires these residues. If
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this were so, it could account for the reported binding of
caldesmon near tropomyosin 142-227. The density seen
near tropomyosin 180-210 and 5-50 in the difference maps
in Fig. 3 may correspond to the binding of caldesmon
domains 1 or 3. It is difficult to reconcile the results of these
x-ray results and the previous solution studies. It is possible
that the studies using fragments of tropomyosin might not
accurately reflect the binding of caldesmon to whole tropo-
myosin molecules joined head to tail and bound on an actin
filament. It is also possible that the strong binding sites
observed in the tropomyosin crystals are an artifact of the
crystal packing, where some caldesmon regions may appear
more prominent in the difference maps because of their
interactions with several nearby tropomyosin molecules.
However, this explanation is unlikely because of the ex-
tremely high solvent content of the tropomyosin crystals
used and the amount of motion known to occur within these
crystals (Chacko and Phillips, 1992).
Biosensor data analysis
Although real time optical evanescence biosensing is a
relatively new technology, it has already been successfully
used to measure the interactions of a wide variety of pro-
teins (Szabo et al., 1995; Yeung et al., 1995). In most cases
the biosensor-determined affinities are similar to the affin-
ities reported with other methods, although there are some
situations where the affinities are not directly comparable.
Data from these new biosensors can be used to extract
accurate association and dissociation rate constants for sim-
ple bimolecular interactions and even for some cases where
the kinetics involve two separate rates for both association
and dissociation. However, there are also some situations
where biosensors cannot accurately extract association and
dissociation rate constants unless a model for the interaction
is known and incorporated into the kinetic analysis (Morton
et al., 1995). These limitations were not obvious to us when
the biosensor data collection began, but it became apparent
that some of the data that were collected for the binding of
caldesmon to immobilized tropomyosin could not be de-
scribed as a simple bimolecular interaction.
There are several possible reasons why the biosensor
data were difficult to analyze. First, the method used to
immobilize tropomyosin probably resulted in multiple
conformations with differing accessibilities of caldesmon
binding sites. Although this scenario does not usually
present a major difficulty in the analysis of biosensor
data (Edwards et al., 1995), in this case it may be prob-
lematic, because the interactions between caldesmon and
tropomyosin are primarily electrostatic and may also
require tropomyosin to be in an elongated, near-linear
state as it is found in muscle. A second complication for
whole caldesmon is that several regions of caldesmon
may bind to tropomyosin, resulting in a combination of
heterogeneous immobilization and multiple binding sites
that was encountered was in the direct measurement of
the dissociation phase. Considerable rebinding was ob-
served, which is not uncommon. However, the usual
remedy of adding an excess amount of the immobilized
protein to the dissociation buffer was not possible be-
cause the muscle tropomyosins self-polymerized and
bound to the immobilized tropomyosin on the biosensor
cuvette. Some dissociation rates were measured directly
when unacetylated tropomyosin was immobilized to the
cuvetttes. These directly measured rates were compared
to the rates derived from the kinetic analysis, and they
agreed with each other within 30%. Thus the authors feel
justified in using the dissociation rates of caldesmon
from the other tropomyosins derived only through kinetic
analysis of the data (Table 3). Overall the dissociation
rates appear to decrease with decreasing salt. A fairly
accurate estimation of overall affinity of whole caldes-
mon and CaD-4 for tropomyosin was obtainable by com-
paring the equilibrium and kinetic data.
The authors realize that the errors are large for many of
the kinetic rates, probably because the results of multiple
experiments using different preparations of caldesmon and
tropomyosin were averaged. Some user error is probably
also included, because these data were collected with a
machine that required manual pipetting of each protein
sample into the cuvette. A more accurate determination of
the rate constants could be determined using a more uniform
protein source and an automated biosensor. The individual
KD's calculated from either the first or second on and off
rates are close to the equilibrium affinities and probably
differ because they represent only a part of the total binding.
As expected, the affinity of caldesmon for tropomyosin was
weaker at higher salt. It was also noticed that the affinity of
CaD-4 for tropomyosin seemed to be slightly less than the
affinity of whole caldesmon. The inability to extract rate
constants for the second phase of some experiments and at
low salt may be due to a greater contribution of nonspecific
binding to the raw data. Overall, the kinetic data seem to
follow the patterns mentioned above, but there are a few
numbers that deviate. The reason for these unusual rates is
not clear but is under investigation.
Caldesmon's affinity for tropomyosin
The affinities of whole caldesmon and CaD-4 for tropomy-
osin reported here are similar, but slightly stronger than
previously measured affinities determined by fluorescence
experiments (Table 4). However, there is considerable vari-
ability in the reported affinities, which seems to be due to
the use of different fluorescent labels and different buffer
conditions. In particular, the ionic strength at which the
experiments are done has a great effect on the affinity
(Table 4). It is also possible that the overall affinity of
caldesmon for immobilized tropomyosin presented here is
probably slightly less than what the actual affinity is, be-
that is difficult to model accurately. One final difficulty
Hnath et al. 1929
cause some of the binding was to less than ideal binding
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TABLE 4 Affinity of chicken gizzard whole caldesmon to tropomyosin as determined by various methods
Method* Salt (mM) pH Affinity (nM) Reference
ANM-Tm 10 NaCl 7.0 129-333 Watson et al., 1990a
"1 50 NaCl it 1000 "
Pyrene-CaD 0 7.2 45 Watson et al., 1990b
DNS-Tm 10 KCl 7.5 25 Fujii et al., 1988
Pyrene-CaD 10 KCl 7.2 270 Horiuchi and Chacko, 1988
if 20 KCI " 588
if 40 KCl " 3300
it 100 KCl " >10,000
Pyrene-Tm 0 7.2 92 Tsuruda et al., 1995
Pyrene-Tm 30 KCl 7.2 400 Huber et al., 1995
lAsys 50 NaCl 7.4 150 This paper
100 NaCl " 500 This paper
150 NaCl " -1000 This paper
*Type of assay: ANM-Tm, tropomyosin labeled with N-(1-anilinonaphthyl-4) maleimide; Pyrene-CaD, caldesmon labeled with N-(1-pyrenyl) maleimide;
DNS-Tm, tropomyosin labeled with dansyl chloride; Pyrene-Tm, tropomyosin labeled with N-(1-pyrenyl) maleimide; IAsys, binding on caldesmon to
unlabeled, immobilized tropomyosin.
sites. Thus it seems that the affinity of whole caldesmon for
tropomyosin may be greater than has been previously esti-
mated using fluorescence techniques, whereas the affinity
of many isolated domains may be less.
The effect of Ca2+/calmodulin on the affinity of caldes-
mon and CaD-4 for tropomyosin was also examined. The
interaction of caldesmon and tropomyosin is known to be
regulated by the binding of Ca2+/calmodulin to caldesmon,
which weakens the affinity of caldesmon for tropomyosin
(Watson et al., 1990a). Previous studies have shown that
CaD-4 contains both of caldesmon's two calmodulin-bind-
ing sites (Marston et al., 1994b; Mezgueldi et al., 1994;
Zhuang et al., 1995). One of the most exciting aspects of
optical biosensors is their ability to examine protein-ligand
interactions in real time. The addition of Ca2+/calmodulin
to caldesmon or CaD-4 bound to tropomyosin on the IAsys
cuvette resulted in a quick release of caldesmon from tro-
pomyosin (Fig. 8).
Nonspecific binding
Although earlier studies suggested that all four caldesmon
domains bind to tropomyosin, most of those binding assays
were done at 10-60 mM salt (Table 4). Several of these
studies reported that binding of caldesmon to tropomyosin
became weaker at higher ionic strengths, and the binding of
most domains could not be easily detected at 100 and 150
mM salt using fluorescent techniques. These reports raise
some questions about the physiological relevance of these
interactions, particularly because caldesmon and tropomy-
osin appear to bind primarily through electrostatic interac-
tions (Huber et al., 1995). No appreciable specific binding
of CaD- 1, CaD-2, or CaD-3 to tropomyosin was observed at
100 and 150 mM salt. However, some nonspecific binding
of CaD-1 and CaD-2 to tropomyosin, myoglobin, and BSA
was observed at 50 mM salt. The results from other recent
studies also suggest that the binding of CaD-3 and CaD- 1
may not be physiologically relevant in smooth muscle,
because CaD-3 only binds to skeletal and nonmuscle tropo-
myosin but not smooth muscle tropomyosin, and CaD-1
may only binds tropomyosin in the absence of actin (Huber
et al., 1995; Lamb et al., 1996; Tsuruda et al., 1995).
However, the binding of CaD-3 to tropomyosin may be
important in nonmuscle caldesmon:tropomyosin interac-
tions (Huber et al., 1995; Lamb et al., 1996). Although the
second domain of caldesmon has been reported to bind to
tropomyosin (Redwood and Marston, 1993), biosensor stud-
ies did not detect specific binding of CaD-2 to tropomyosin.
Another laboratory has also been unable to detect binding of
domain 2 of caldesmon to tropomyosin (A. Mak, personal
communication). The studies undertaken here on the IAsys
were carefully done with several parallel negative controls
to ensure that weak, nonspecific binding was not mistaken
for specific interaction.
Comparison of caldesmon to troponin
Numerous studies suggest that caldesmon may function in a
manner similar to that of troponin in the regulation of
muscle contraction (Fraser and Marston, 1995; Marston et
al., 1994a; Marston and Smith, 1985). However, it has
previously been noted that caldesmon and troponin show
little similarity at the molecular level, and therefore the
details of how muscle contraction is regulated by these two
proteins are probably different (Marston et al., 1994a;
Vibert et al., 1993). Several observations suggest that the
interaction of caldesmon and tropomyosin is significantly
different from the way that troponin and tropomyosin inter-
act. The fact that caldesmon bound similarly to skeletal,
smooth, and unacetylated tropomyosins, as measured with
the TAsys, is one significant difference. This result confirms
previous reports that caldesmon binding to tropomyosin
does not appear to require the head-to-tail overlap of tropo-
myosin molecules (Watson et al., 1990b). On the other
hand, troponin binding is highly dependent on the nature of
the head-to-tail overlap and binds significantly less tightly
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to unacetylated tropomyosin (which does not polymerize)
than it does to polymerized tropomyosin (Pearlstone and
Smillie, 1982). Another significant difference in the binding
of troponin and caldesmon to tropomyosin is in the affinities
of the two proteins for tropomyosin. Comparative studies
with the IAsys found that caldesmon has only micromolar
affinity at 150 mM salt (this paper), whereas troponin has
-100 nanomolar affinity at 150 mM salt and micromolar
affinity at 500 mM salt (E. J. Hnath, unpublished results).
Although caldesmon is able to regulate actin:myosin inter-
action through tropomyosin in vitro, it remains to be shown
that this regulation occurs at a significant level in vivo
(Fraser and Marston, 1995; Pfitzer et al., 1993; Taggart and
Marston, 1988). Caldesmon has been shown to be able to
cross-link actin and myosin filaments (Katayama et al.,
1995). In this role the binding of caldesmon to tropomyosin
may be important in the alignment of caldesmon on the
actin filament. Caldesmon and tropomyosin have also been
shown to stabilize actin filaments and prevent actin depo-
lymerization in nonmuscle cells (Hegmann et al., 1991;
Warren et al., 1994; Yamashiro-Matsumura and Mat-
sumura, 1988). The details of how caldesmon may affect
smooth muscle contraction by several different mechanisms
and the roles of caldesmon in nonmuscle cells remain to be
defined.
A model of caldesmon binding to tropomyosin in
the thin filament
Based on results presented in this paper and previously
published data, four models of how caldesmon may interact
with tropomyosin in the thin filament have been constructed
(Fig. 9). These models are similar to earlier models in the
general arrangement of caldesmon, tropomyosin, and actin,
but position caldesmon on tropomyosin at different sites
(Huber et al., 1995; Tsuruda et al., 1995). All previous
models have placed caldesmon on tropomyosin, assuming
that the caldesmon binds most tightly to tropomyosin 170-
200 and assuming an antiparallel orientation of caldesmon
and tropomyosin by analogy with troponin T. It is difficult
to reconcile the x-ray results of tropomyosin residues 70-
100 and/or 230-260 interacting most tightly with caldes-
mon with the previous results. The binding of some region
of caldesmon near tropomyosin 170-200 is encouraging.
This suggests that these x-ray results may be consistent with
the earlier solution studies, but that for some reason the
tighter binding of CaD-4 to tropomyosin 70-100 and/or
230-260 was not detected earlier. It is possible that the
previous studies with fragments of tropomyosin may not
accurately reflect the binding of an elongated caldesmon
molecule to tropomyosin filaments. It should also be
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FIGURE 9 Several possible models of caldesmon and tropomyosin interactions in smooth muscle thin filaments. Three tropomyosin molecules are shown
in each model, and the domain structure of caldesmon is depicted as previously proposed (Marston and Redwood, 1991). Areas of tropomyosin where
caldesmon appeared to be in close association, as observed in the x-ray data difference maps, are highlighted in gray. Dark gray indicates the strongest
binding sights and lighter gray shows the weaker contacts. (A) Model with tropomyosin and caldesmon in a parallel orientation with the C-termini of both
molecules almost aligned. (B) Another model with tropomyosin and caldesmon aligned parallel, but with the caldesmon domain 4 aligned with tropomyosin
residues 70-100. (C) Caldesmon and tropomyosin in an antiparallel orientation, with the C-terminus of caldesmon aligned with tropomyosin 70-100. (D)
A second antiparallel model, with the C-termini of caldesmon and tropomyosin approximately aligned.
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pointed out that because these studies did not include actin
and because both tropomyosin and caldesmon bind to actin,
these models may not accurately depict the interactions
between these proteins that occur in muscle tissue. How-
ever, we have tried to incorporate and integrate information
about caldesmon-tropomyosin-actin interactions from a va-
riety of other studies into these models, and as such, they
represent that most probable arrangements, given the cur-
rent state of knowledge.
In the tropomyosin crystal a caldesmon molecule may not
bind in an elongated fashion along two adjacent tropomy-
osin molecules as it is depicted in the model. Thus it is
possible that a single caldesmon molecule may wind
through the crystal, contacting several tropomyosin mole-
cules that are in close proximity but are not joined head to
tail. It is also possible that only the C-terminal domain of
caldesmon may be bound to every single tropomyosin mol-
ecule and that the N-terminus may be unattached. Because
there is no way of knowing the actual arrangement of
caldesmon molecules within the crystal, the x-ray data can
only be used to reveal the regions of tropomyosin that are in
close contact with caldesmon. Furthermore, in the Bailey
crystals tropomyosin molecules cross back and forth across
other tropomyosin molecules. The area of closest contact
between tropomyosin molecules is between residues 70-
100 of one molecule and 230-260 of another tropomyosin.
Unfortunately, this is also near where the tightest binding of
caldesmon to tropomyosin is observed, and it is not possible
to determine which region is responsible for the tight bind-
ing of caldesmon. Currently there is no direct evidence to
support one model over the other, although the authors think
that models B and C (Fig. 9) are more probable, because it
is easier to trace longer regions of caldesmon close to
tropomyosin in these models.
Many studies have been done on the structure of thin
filaments in various muscle tissues. The orientation of tro-
pomyosin on actin filaments in skeletal muscle has been
defined, and it seems reasonable to assume that smooth
muscle tropomyosin would bind in the same direction to
smooth muscle actin filaments. Knowledge of the polarity
of the actin filaments from the EM studies should also be
able to define the direction of caldesmon binding to actin
and could be used to construct a more accurate model of
tropomyosin and caldesmon binding to the actin filament in
smooth muscle. Unfortunately, myosin S-1 labeling of
smooth muscle actin:caldesmon filaments has not yet
clearly revealed the orientation of caldesmon to actin (E.
Katayama, personal communication). It is hoped that more
work will determine the polarity of caldesmon to the actin
filament and tropomyosin.
Although many questions still remain about the interac-
tions of caldesmon and tropomyosin, the results of this
study and several other recent publications have helped
define some of the more probable interactions (Huber et al.,
1995; Katayama and Ikebe, 1995; Tsuruda et al., 1995).
Caldesmon appears to be attached to tropomyosin residues
70-100 andl/or 230-260 through residues 597-756. Other
weaker binding sites may be located in domains 1, 2, and/or
3 of caldesmon for tropomyosin residues 180-210 and
5-50. The specific tropomyosin residues involved in the
tight binding of caldesmon cannot be unambiguously deter-
mined, but based on the x-ray data they appear to be either
70-100 and/or 230-260. There may also be some regions
of caldesmon that interact only weakly with tropomyosin
but bind tightly to actin in muscle cells. Thus there is still
much to be determined about the interactions of caldesmon
and tropomyosin in smooth muscle thin filaments.
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